Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

ResMed Inc (RMD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ResMed's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
218.06 +34.64    +18.89%
- Closed. Currency in USD ( Disclaimer )
After Hours
220.00
+1.94
+0.89%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 4,265,114
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 201.92 - 218.38
ResMed 218.06 +34.64 +18.89%

NYSE:RMD Financials

 
A brief overview of the NYSE:RMD financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of ResMed over time.

ResMed Inc. reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was USD 1,196.98 million compared to USD 1,116.9 million a year ago. Net income was USD 300.49 million compared to USD 232.5 million a year ago. Basic earnings per share from continuing operations was USD 2.04 compared to USD 1.58 a year ago. Diluted earnings per share from continuing operations was USD 2.04 compared to USD 1.58 a year ago.For the nine months, sales was USD 3,462.1 million compared to USD 3,100.94 million a year ago. Net income was USD 728.72 million compared to USD 667.89 million a year ago. Basic earnings per share from continuing operations was USD 4.96 compared to USD 4.55 a year ago. Diluted earnings per share from continuing operations was USD 4.94 compared to USD 4.53 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

RMD Income Statement

Gross margin TTM 56.51%
Operating margin TTM 28.12%
Net Profit margin TTM 20.91%
Return on Investment TTM 17.11%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 1196.98 1162.8 1102.32 1122.06
Gross Profit 700.59 655.19 608.97 625.78
Operating Income 374.58 339.32 289 286.24
Net Income 300.49 208.8 219.42 229.66

RMD Balance Sheet

Quick Ratio MRQ 1.32
Current Ratio MRQ 3.04
LT Debt to Equity MRQ 21.53%
Total Debt to Equity MRQ 25.22%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 6814.56 6905.09 6740.79 6751.71
Total Liabilities 2184.64 2423.23 2490.41 2621.8
Total Equity 4629.92 4481.85 4250.38 4129.9

RMD Cash Flow Statement

Cash Flow/Share TTM 8.16
Revenue/Share TTM 31.21
Operating Cash Flow  52.01%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 402.03 272.83 286.28 237.44
Cash From Investing Activities -33.15 -41.14 -148.98 -46.52
Cash From Financing Activities -335.91 -238.96 -151.13 -188.59
Net Change in Cash 27.66 1.15 -18.79 -0.003
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RMD Comments

Write your thoughts about ResMed Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
ferney Restrepo
ferney Restrepo Aug 05, 2023 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well it is time to buy some of this company. this should be around 215
Think Twice
ThinkTwice_57 Apr 16, 2021 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well, there is definitely some climb before earnings. Stock looks good now, let's hope for good results.
Chengran Su
Chengran Su Mar 19, 2020 12:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well.. My friend who works here says they are working as 7/24 to fulfill the orders coming from hospitals. They are lacking ventilator and there are huge demands coming from private family who are scared they will not get enough medical resource...
Jing Chen
Jing Chen Mar 13, 2020 2:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Resmed shouldn't bee dropping so much with the market. Did you guys forget that Resmed sells ventilators and mask for patient? They supply them to hospitals and now the demand is even stronger than before for these healthcare products
Bruce Young
Bruce Young May 01, 2019 7:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold a put spread this morning before IV crush tomorrow!
Matej Nespala
Matej Nespala Feb 11, 2019 9:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RMD is on atractive strong support, long
Ryan Lekuku
Ryan Lekuku Feb 07, 2019 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to buy
Zhen Yuan
Zhen Yuan Jan 31, 2019 11:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Might be a big drop tomorrow?
Ryan Houck
Ryan Houck Jan 31, 2019 11:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How did u know ?
Ryan Lekuku
Ryan Lekuku Jan 10, 2019 2:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Short at 115.673
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email